GRB7 and familial pancreatic carcinoma: In a mouse model, Grb7 peptide inhibitor, which selectively blocks the interactions between Grb7 and ERBB family proteins or FAK [6,7] as well as blocking the phosphorylation of Grb7 protein, significantly ablates the peritoneal metastasis of pancreatic cancer cells [6].